About
Modifications of Existing Drugs
Areas of Focus
Categories
Small Molecule Pharmaceutical
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
3
As Collaborator
2
Total Enrollment
512
By Phase
PHASE1: 1PHASE2: 2PHASE3: 2
By Status
COMPLETED: 3ENROLLING_BY_INVITATION: 1RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07125066Collaborator
An Individual Patient, Open Label Study to Use ACER-001 to Treat Combined D,L-2 Hydroxyglutaric Aciduria (C-2HGA)
PHASE1Enrolling by invitation
1 participants
Started: Jul 30, 2025 · Completed: Dec 31, 2027
NCT06773026Collaborator
Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)
PHASE2Recruiting
24 participants
Started: Jun 30, 2025 · Completed: Jul 31, 2027
NCT05668754Lead Sponsor
Placebo-Controlled, Double-Blind, Study to Determine the Safety and Efficacy of SDX in Patients With IH
PHASE2Completed
50 participants
Started: Dec 28, 2022 · Completed: Mar 21, 2024
NCT03460652Lead Sponsor
KP415 Open-Label Safety Study in Children (6-12 Years of Age) With ADHD
PHASE3Completed
282 participants
Started: Mar 13, 2018 · Completed: Jul 9, 2019
NCT03292952Lead Sponsor
KP415 Classroom Study in Children (6-12 Years of Age) With ADHD
PHASE3Completed
155 participants
Started: Dec 20, 2017 · Completed: May 16, 2018
Locations (1)
Headquarters
Frederiksberg, Denmark
Map
Loading map...